Abortion hotlines around the world: a mixed-methods systematic and descriptive review.


Journal

Sexual and reproductive health matters
ISSN: 2641-0397
Titre abrégé: Sex Reprod Health Matters
Pays: England
ID NLM: 101743493

Informations de publication

Date de publication:
Dec 2021
Historique:
entrez: 29 4 2021
pubmed: 30 4 2021
medline: 29 10 2021
Statut: ppublish

Résumé

Barriers to access abortion services globally have led to the development of alternative methods to assist and support women who seek an abortion. One such method is the use of hotlines, currently utilised globally for abortion care. This review aimed to understand (1) how abortion hotlines facilitate access to abortion; and (2) how women and stakeholders describe the impact of hotlines on abortion access. Published quantitative and qualitative studies and grey literature were systematically reviewed alongside an identification and description of abortion hotlines in the public domain. Our findings highlight that the existence of abortion hotlines is highly context-dependent. They may exist either as an independent community-based model of care, or as part of formal care pathways within the health system. Hotlines operating in contexts with legal restrictions seem to be broader in scope and will use innovative approaches to adapt to their setting and reach hard-to-reach populations. All the abortion hotlines that provided information on a data extraction form used evidence-based guidelines but women seeking medical abortion still struggle to access quality medications. There is limited data in general on abortion hotlines, especially on the user and provider experience. Abortion hotlines have the potential to facilitate access to safe abortion care through evidence-based information and to decrease maternal mortality and morbidity from unsafe abortions for women and girls globally.

Identifiants

pubmed: 33910479
doi: 10.1080/26410397.2021.1907027
pmc: PMC8097399
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1907027

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

Reprod Health Matters. 2015 May;23(45):47-57
pubmed: 26278832
Lancet. 2017 Nov 25;390(10110):2372-2381
pubmed: 28964589
Contraception. 2018 Feb;97(2):86-89
pubmed: 28780241
BJOG. 2019 Aug;126(9):1094-1102
pubmed: 30869829
Am J Public Health. 2016 Nov;106(11):2071-2075
pubmed: 27631756
Obstet Gynecol Int. 2014;2014:913241
pubmed: 24693291
Lancet. 2016 Jul 16;388(10041):258-67
pubmed: 27179755
Contraception. 2018 Feb;97(2):122-129
pubmed: 28780239
BMJ Sex Reprod Health. 2018 Jul 18;:
pubmed: 30021794
Int J Gynaecol Obstet. 2016 Aug;134 Suppl 1:S3-6
pubmed: 27577024
Reprod Health Matters. 2014 Nov;22(44):70-81
pubmed: 25555764
Reprod Health. 2012 Dec 22;9(1):34
pubmed: 23259660
BMJ Glob Health. 2020 Jul;5(7):
pubmed: 32690484
Perspect Sex Reprod Health. 2018 Dec;50(4):157-163
pubmed: 29992793
Contraception. 2020 Jul;102(1):61-65
pubmed: 32304768
BMC Med Res Methodol. 2008 Jul 10;8:45
pubmed: 18616818
Reprod Health Matters. 2018 Nov;26(54):13-19
pubmed: 30231807
AIDS Patient Care STDS. 2005 Oct;19(10):684-9
pubmed: 16232052
Health Hum Rights. 2020 Jun;22(1):237-249
pubmed: 32669804
Reprod Health Matters. 2015 Feb;22(44 Suppl 1):4-15
pubmed: 25702064
Int J Gynaecol Obstet. 2020 Apr;149(1):48-55
pubmed: 31834936
Contraception. 2018 Feb;97(2):108-115
pubmed: 28801052
Contraception. 2020 Aug;102(2):91-98
pubmed: 32360817
Obstet Gynecol. 2017 Oct;130(4):778-782
pubmed: 28885427
Contraception. 2018 Feb;97(2):137-143
pubmed: 28935219
Sex Reprod Health Matters. 2020 Dec;28(1):1779633
pubmed: 32602789
J Int Assoc Physicians AIDS Care (Chic). 2008 May-Jun;7(3):130-2
pubmed: 18441254
Best Pract Res Clin Obstet Gynaecol. 2020 Feb;63:87-110
pubmed: 31859163
PLoS One. 2018 Jan 10;13(1):e0189195
pubmed: 29320513
Mhealth. 2018 Feb 01;4:3
pubmed: 29552565
Lancet Glob Health. 2020 Sep;8(9):e1152-e1161
pubmed: 32710833
Women Health. 2012;52(1):88-100
pubmed: 22324360

Auteurs

Roopan K Gill (RK)

Consultant, UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland; Clinical Assistant Professor, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada.

Amanda Cleeve (A)

Consultant, UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland; Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden; South General Hospital, Stockholm, Sweden.

Antonella F Lavelanet (AF)

Medical Officer, Department of Sexual and Reproductive Health and Research and UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH